Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Oxford University Press (OUP) ; 2017
    In:  European Journal of Endocrinology Vol. 176, No. 1 ( 2017-01), p. 11-19
    In: European Journal of Endocrinology, Oxford University Press (OUP), Vol. 176, No. 1 ( 2017-01), p. 11-19
    Abstract: Hypomagnesemia (plasma magnesium (Mg 2+ ) concentration 〈 0.7 mmol/L) has been described in patients with type 2 diabetes. Polypharmacy is inevitable when treating a complex disease such as type 2 diabetes and could explain disturbances in the plasma Mg 2+ concentration. In this study, we aimed to establish the extent of hypomagnesemia in a cohort of type 2 diabetes patients and to identify the determinants of plasma Mg 2+ levels. Methods Patient data and samples of 395 type 2 diabetes patients were investigated. Plasma Mg 2+ concentrations were measured using a spectrophotometric assay. Using Pearson correlation analyses, variables were correlated to plasma Mg 2+ levels. After excluding confounding variables, all parameters correlating ( P   〈  0.1) with plasma Mg 2+ were included in a stepwise backward regression model. Results The mean plasma Mg 2+ concentration in this cohort was 0.74 ± 0.10 mmol/L. In total, 121 patients (30.6%) suffered from hypomagnesemia. Both plasma triglyceride ( r  = −0.273, P   〈  0.001) and actual glucose levels ( r  = −0.231, P   〈  0.001) negatively correlated with the plasma Mg 2+ concentration. Patients using metformin ( n  = 251, 62%), proton pump inhibitors ( n  = 179, 45%) or β-adrenergic receptor agonists ( n  = 31, 8%) displayed reduced plasma Mg 2+ levels. Insulin use ( n  = 299, 76%) positively correlated with plasma Mg 2+ levels. The model predicted ( R 2 ) 20% of all variance in the plasma Mg 2+ concentration. Conclusions Hypomagnesemia is highly prevalent in type 2 diabetes patients. Plasma triglycerides and glucose levels are major determinants of the plasma Mg 2+ concentration, whereas only a minor part ( 〈 10%) of hypomagnesemia can be explained by drug intake, excluding polypharmacy as a major cause for hypomagnesemia in type 2 diabetes.
    Type of Medium: Online Resource
    ISSN: 0804-4643 , 1479-683X
    RVK:
    Language: Unknown
    Publisher: Oxford University Press (OUP)
    Publication Date: 2017
    detail.hit.zdb_id: 1485160-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages